Breaking Down Zhejiang Runtu Co., Ltd. Financial Health: Key Insights for Investors

Zhejiang Runtu (002440.SZ) presents a compact yet intriguing financial picture: operating revenue of 4.163 billion yuan in the first three quarters of 2025 (a 2.25% year-on-year rise) after a full-year 2024 revenue of 5.70 billion yuan, while Q1 2025 slipped to 1.28 billion yuan (down 21.26% vs Q4 2024) and the 52‑week stock range sits between 5.80 and 8.50 yuan; profitability shows a sharper move with net profit attributable to shareholders at 225 million yuan in the first three quarters of 2025 (a 49.10% increase YoY) and basic EPS up to 0.20 yuan from 0.13, against a full‑year diluted EPS of 0.19 yuan and net margins around 4.5% with ROE near 2.8%; liquidity and balance sheet strength stand out-operating cash flow reached 548 million yuan in 2024 while capital expenditure was only 89 million, cash and equivalents total 1.18 billion yuan versus negligible total debt of 1.35 million yuan, leaving an enterprise value of 6.97 billion yuan and market capitalization of 8.39 billion yuan; valuation metrics include a P/E of 29.25 and a beta of 0.405, but investors should weigh this against an earnings decline trend of -39.5% annually and tepid revenue growth (≈0.37%-0.4%); read on to unpack the implications for investment strategy and risk exposure.

Zhejiang Runtu Co., Ltd. (002440.SZ) - Revenue Analysis

• Operating revenue (first 3 quarters 2025): 4.163 billion CNY - +2.25% year‑on‑year.
• Full fiscal year 2024 revenue: 5.70 billion CNY - +1.91% vs. 2023.
• Longer‑term trend: ~0.4% average annual revenue growth (modest/near‑flat growth).
• Q1 2025 revenue: 1.28 billion CNY - down 21.26% vs. Q4 2024.
• 52‑week stock price range: 5.80-8.50 CNY, implying market reaction to revenue volatility.
• Market capitalization (as of 2025‑11‑07): ~8.39 billion CNY.

• Quarterly volatility: Large Q1 drop (21.26% vs. Q4 2024) highlights seasonality or short‑term demand swing risk.
• Scale and valuation: Market cap ~8.39 billion CNY vs. annual revenue ~5.7 billion CNY - revenue multiple and investor expectations warrant monitoring.
• Investor reference: Exploring Zhejiang Runtu Co., Ltd. Investor Profile: Who's Buying and Why?

Zhejiang Runtu Co., Ltd. (002440.SZ) - Profitability Metrics

Key profitability indicators for Zhejiang Runtu Co., Ltd. show a company with improving reported earnings and solid operating cash generation, alongside relatively modest margins and returns on equity.

• Net profit attributable to shareholders (first three quarters of 2025): ¥225 million - a 49.10% year‑over‑year increase.
• Basic EPS (first three quarters of 2025): ¥0.20, up from ¥0.13 in the same period of 2024.
• Diluted EPS (full fiscal year 2024): ¥0.19.
• Net profit margin (full fiscal year 2024): ≈3.7% (reported).
• Reported net margins cited elsewhere: 4.5% (company metric reference).
• Return on equity (ROE): 2.8%.
• Operating cash flow (full fiscal year 2024): ¥548 million; Capital expenditures: ¥89 million.

Implications for investors:

• Strong operating cash flow (¥548m) far exceeds capex (¥89m), supporting cash‑based flexibility and potential shareholder returns or debt reduction.
• Significant YoY profit growth in the first three quarters of 2025 (¥225m, +49.10%) indicates operational momentum but aggregate annual margins remain modest (3.7%-4.5%).
• Small absolute EPS figures (¥0.19 diluted FY2024; ¥0.20 basic for Q1-Q3 2025) mean valuation sensitivity to profit swings and share count changes.
• ROE of 2.8% suggests limited efficiency in converting equity into earnings - a consideration for capital allocation expectations.

Further context and shareholder composition can be found here: Exploring Zhejiang Runtu Co., Ltd. Investor Profile: Who's Buying and Why?

Zhejiang Runtu Co., Ltd. (002440.SZ) - Debt vs. Equity Structure

• Total debt: 1.35 million yuan - effectively immaterial relative to company scale.
• Cash and cash equivalents: 1.18 billion yuan - substantial liquid resources on hand.
• Net cash position: cash exceeds debt by ~1.17865 billion yuan, signaling net cash status.
• Enterprise value (EV): 6.97 billion yuan - includes market cap, debt, and cash adjustments.
• Market capitalization: 8.39 billion yuan - equity market valuation.

• Implied leverage: With debt at 1.35 million yuan against EV of 6.97 billion yuan, debt contributes negligibly to capital structure.
• Debt-to-equity implication: Given minimal debt and market cap of 8.39 billion yuan, the effective debt-to-equity ratio is near zero, consistent with a conservative financing stance.
• Financial flexibility: Large cash holdings relative to debt provide capacity for buybacks, dividends, M&A, or cushioning through downturns without new debt issuance.

Zhejiang Runtu Co., Ltd. (002440.SZ) - Liquidity and Solvency

• Operating cash flow (2024): 548 million yuan vs. capital expenditures: 89 million yuan - substantial free cash inflow supporting operations and discretionary uses.
• Net cash position: company reports a net cash stance, signaling cash holdings exceed interest-bearing debt and providing financial flexibility.
• Debt profile: minimal debt and a conservative capital structure; debt-to-equity not explicitly disclosed but leverage is low.
• Valuation context: enterprise value of 6.97 billion yuan and market capitalization of 8.39 billion yuan - equity value exceeds EV, consistent with net cash.
• Profitability: ROE of 2.8% and net margin of 4.5%, indicating moderate returns on equity and modest profitability per sales.

• Liquidity implications: strong operating cash flow cover for capex and working capital reduces refinancing and short-term liquidity risk.
• Solvency implications: net cash and low leverage lower bankruptcy risk and expand strategic optionality (M&A, buybacks, dividends).
• Valuation notes: EV below market cap reflects cash-rich balance sheet; investors should weight modest ROE and margins when assessing returns.

Zhejiang Runtu Co., Ltd. (002440.SZ) - Valuation Analysis

• Market capitalization: 8.39 billion yuan - reflects equity market value.
• Enterprise value (EV): 6.97 billion yuan - captures total firm value including debt and cash.
• Price-to-earnings (P/E): 29.25 - a moderate valuation multiple relative to current earnings.
• Diluted EPS: 0.19 yuan - per-share earnings available to shareholders.
• Beta: 0.405 - substantially less volatile than the broader market.
• Return on equity (ROE): 2.8% - indicates modest shareholder returns.
• Net margin: 4.5% - shows moderate profitability on sales.

• P/E of 29.25 relative to EPS of 0.19 yuan implies a share price consistent with market-cap data but suggests limited absolute earnings power - investors are paying for future earnings growth or stability rather than current high profitability.
• EV (6.97 bn) being below market cap (8.39 bn) typically signals a net cash position or minimal leverage; check the balance sheet for cash/debt breakdown when assessing takeover value vs. equity value.
• Low beta (0.405) reduces expected volatility - attractive for risk-averse investors, but may compress upside in bull markets; combine with ROE (2.8%) and net margin (4.5%) to assess return potential versus safety.
• ROE and net margin indicate the company is generating modest returns on equity and sales; to justify the P/E, investors should look for improving margin trends, meaningful margin expansion initiatives, or scalable revenue growth.

Zhejiang Runtu Co., Ltd. (002440.SZ) - Risk Factors

• Steep earnings deterioration: earnings have fallen at an average annual rate of -39.5%, materially underperforming the Chemicals industry average decline of -0.7% per year.
• Revenue stagnation risk: revenue growth is a marginal 0.37% annually, signaling limited top-line momentum to offset shrinking profitability.
• Modest profitability: ROE is 2.79% and net margin is 4.54%, indicating the company generates only modest returns on equity and limited profit per unit of revenue.
• Low market sensitivity: beta of 0.405 implies lower volatility but also suggests weaker upside capture in broad market rallies, potentially constraining capital appreciation.
• Conservative balance sheet: available disclosures point to minimal debt, implying limited financial leverage but also reduced upside from debt-fueled growth initiatives.
• Valuation scale: market capitalization stands at ¥8.39 billion, situating the company among small-to-mid cap players with attendant liquidity and coverage considerations.

• Operational risk: protracted earnings decline raises concerns about competitiveness, cost structure, product mix, or demand for the company's chemical products.
• Growth financing trade-off: low leverage reduces solvency risk but may limit the company's ability to invest aggressively to reverse revenue and earnings trends.
• Investor sentiment and liquidity: mid-cap valuation and lower beta can lead to muted institutional interest and periods of thin trading.
• Macroeconomic and industry cyclicality: as part of the Chemicals sector, exposure to raw material price swings, regulatory changes, and global demand cycles increases earnings volatility.
• Execution risk: recovery depends on clear strategic initiatives to restore margins and ROE; failure to execute would prolong value erosion.

Zhejiang Runtu Co., Ltd. (002440.SZ) - Growth Opportunities

• Domestic leadership: Established manufacturing base in Zhejiang province-China's chemical industry hub-provides logistics, supplier density and skilled labor advantages that lower unit costs and shorten time-to-market.
• Product diversification: A portfolio of approximately 300 chemical varieties enables cross-selling, customized solutions for textile customers and resilience against single-product demand shocks.
• International distribution: Sales channels across Southeast Asia, the Middle East, Europe and the United States create revenue diversification and exposure to higher-margin export markets.
• Net cash position: Reported net cash posture (cash and equivalents exceeding short-term borrowings) underpins the company's ability to fund working capital, capex and selective M&A without immediate reliance on external financing.
• Operational track record: Continuous operation since 1986 yields institutional knowledge, established customer relationships and process optimization-benefits that compound over decades.
• Capital returns: A shareholder-friendly policy that has included regular dividends supports equity investor confidence and can enhance total shareholder return when combined with growth.

• Export expansion: Leveraging existing distribution to increase share in higher-margin markets (EU, US) and reduce reliance on domestic cyclicality.
• New product development: Using R&D to convert proprietary chemistries into differentiated, higher-margin specialty products tailored to textile and adjacent industrial customers.
• Channel deepening in Southeast Asia and MENA: Local partnerships, distribution agreements and targeted marketing can raise penetration with limited incremental capex.
• Upstream/downstream integration: Selective vertical moves (raw material securing or formulation services) could improve margin stability and customer lock-in.
• Capital deployment: With a net cash position, management can pursue opportunistic M&A, capacity upgrades or sustained dividend programs without destabilizing balance sheet metrics.